Lurasidone Extended Use Study

Clinical trial NCT01485640 · COMPLETED

Trial details

NCT number: NCT01485640
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Bipolar Disorder

Start date: 2011-06-01
Primary completion: 2014-02-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.